Hui Yi Shan, MD

I became a nephrologist because the kidney is a fascinating organ that plays a critical function in maintaining homeostasis for the body. It is composed of filtering units that keep the important nutrients inside our body and excrete the excess. My particular clinical interests are to treat patients with diseases that affect these filtering units called the glomeruli. These include diseases such as lupus nephritis, vasculitis, membranous nephropathy and IgA nephropathy that are often challenging to treat. I would like to establish a trusting relationship with my patients to work together to prevent worsening of their kidney diseases and hopefully reverse their conditions.

Dr. Shan earned her medical degree from New York University School of Medicine. She performed her residency at New York University Medical Center, followed by a Nephrology Fellowship at Beth Israel Deaconess Medical Center- Harvard Medical School.

Dr. Shan’s clinic areas of expertise:

ADVANCED KIDNEY DISEASES CLINIC

Dr. Shan has broad experience in managing patients with advanced kidney disease. She previously served as a nephrology consultant at New York University Medical Center and Kaiser Permanente. Since 2015 she has been working USC.

CYSTIC AND INTERSTITIAL DISEASES CLINIC

Dr. Shan has broad experience in managing patients with advanced kidney diseases. Her care of patients with cystic diseases focuses on delaying progression of kidney disease and the appropriate transition to transplantation or renal replacement therapy.

GLOMERULOPATHY CLINIC

Dr. Shan has broad experience in the care of patients with glomerular kidney diseases. She is utilizing multicenter clinical research studies to advance patient care and knowledge in the area of glomerulopathies.

• Barnard College: Helen R. Downes Prize, 1999
• Barnard College: Mary E. Allison Prize, 1999
• Barnard College, Department of Biology: Spiera Family Prize, 1999

• Renal-Limited Thrombotic Microangiopathy in a Patient Who Received Gemcitabine, Ramucirumab, and Pembrolizumab: A Case Report and Literature Review Cureus. 2024 Feb; 16(2):e53669. . View in PubMed
• Effectiveness of Rituximab and Its Biosimilar in Treating Adult Steroid-Dependent Minimal Change Disease and Relapse Cureus. 2023 Nov; 15(11):e49200. . View in PubMed
• Siglec-7 as a Novel Biomarker to Predict Mortality in Decompensated Cirrhosis and Acute Kidney Injury Dig Dis Sci. 2016 12; 61(12):3609-3620. . View in PubMed
• Successful management of intractable gross hematuria with vasopressin in polycystic kidney disease J Urol Ren Dis. 2016; J113. . View in PubMed
• A method for distinguishing the intended margins for a melanoma from the tissue cones after surgical excision Int J Dermatol. 2011 Dec; 50(12):1560-3. . View in PubMed
• Use of circulating antiangiogenic factors to differentiate other hypertensive disorders from preeclampsia in a pregnant woman on dialysis Am J Kidney Dis. 2008 Jun; 51(6):1029-32. . View in PubMed
• Severe protracted fever following pneumococcal vaccine Am J Med Sci. 2006 Dec; 332(6):351-3. . View in PubMed

• Elkayam, Uri